Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal evaluation in pulmonary hypertension: Contextualizing native T1 mapping.

Respiratory medicine and research·2026
Same author

Frailty in COPD: Early presence, future consequences.

Respiratory medicine and research·2026
Same author

Novel Role of Von Willebrand Factor-αvβ3 Integrin in Human Pulmonary Artery Smooth Muscle Cell.

American journal of respiratory cell and molecular biology·2026
Same author

A meta-analysis supporting the role of positive airway pressure therapy in lowering pulmonary artery pressure in obstructive sleep apnoea and obesity hypoventilation syndrome with severe obstructive sleep apnoea.

The European respiratory journal·2026
Same author

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry.

The European respiratory journal·2026
Same author

Cardiac MRI differentiates classical idiopathic pulmonary arterial hypertension from lung phenotype and group 3 pulmonary hypertension.

Respiratory medicine and research·2026

Related Experiment Video

Updated: May 30, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

[From COPD to chronic respiratory failure].

François Chabot1, Emmanuel Gomez, Anne Guillaumot

  • 1CHU de Nancy, hôpital de Brabois, service des maladies respiratoires et réanimation respiratoire, 54500 Vandoeuvre-les-Nancy. f.chabot@chu-nancy.fr

La Revue Du Praticien
|August 11, 2011
PubMed
Summary
This summary is machine-generated.

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease, primarily caused by smoking, leading to airflow obstruction and breathing difficulties. Prognosis depends on airflow limitation, BMI, and other factors, with common causes of death including respiratory insufficiency and cardiovascular disease.

More Related Videos

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Related Experiment Videos

Last Updated: May 30, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Area of Science:

  • Pulmonology
  • Respiratory Medicine

Context:

  • Chronic obstructive pulmonary disease (COPD) is a major global health issue characterized by persistent airflow limitation.
  • Tobacco smoking is the primary etiological factor, triggering abnormal pulmonary and systemic inflammatory responses.
  • The disease often involves extrapulmonary effects and comorbidities that exacerbate its severity.

Purpose:

  • To define COPD and its diagnostic criteria.
  • To outline the spirometric classification and staging of COPD severity.
  • To discuss the natural history, prognosis assessment, and common causes of mortality in COPD.

Summary:

  • COPD involves irreversible airflow obstruction (postbronchodilator FEV1/FVC ratio < 0.7), progressive airways obstruction, and hyperinflation causing dyspnea.
  • Prognostic assessment integrates spirometric severity (FEV1) with body mass index (BMI), dyspnea, and exercise impairment.
  • The disease process leads to gas exchange abnormalities, chronic respiratory insufficiency, and pulmonary hypertension.

Impact:

  • Understanding COPD's pathophysiology and progression is crucial for effective management.
  • Accurate staging and prognostic assessment aid in tailoring treatment strategies.
  • Identifying key risk factors and comorbidities can help mitigate mortality from respiratory insufficiency, cardiovascular disease, and lung cancer.